For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed at $17.52 up 1.92% from its previous closing price of $17.19. In other words, the price has increased by $1.92 from its previous closing price. On the day, 11.14 million shares were traded.
Ratios:
For a deeper understanding of Teva- Pharmaceutical Industries Ltd. ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.64. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 2.71 whereas as Long-Term Debt/Eq ratio is at 2.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on May 28, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On May 12, 2025, JP Morgan Upgraded its rating to Overweight which previously was Neutral but kept the price unchanged to $23.
Argus Upgraded its Hold to Buy on July 10, 2024, while the target price for the stock was maintained at $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 03 ’25 when Shields Matthew bought 6,206 shares for $17.02 per share.
Sabag Mark sold 337,915 shares of TEVA for $6,097,304 on May 08 ’25. The See “Remarks” now owns 150,996 shares after completing the transaction at $18.04 per share. On May 08 ’25, another insider, Sabag Mark, who serves as the Officer of the company, bought 337,915 shares for $18.04 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.21 while its Price-to-Book (P/B) ratio in mrq is 3.21.
Stock Price History:
Over the past 52 weeks, TEVA has reached a high of $22.80, while it has fallen to a 52-week low of $12.47. The 50-Day Moving Average of the stock is 11.51%, while the 200-Day Moving Average is calculated to be -0.08%.
Shares Statistics:
A total of 1.15B shares are outstanding, with a floating share count of 1.15B. Insiders hold about 0.01% of the company’s shares, while institutions hold 62.95% stake in the company.
